Severe intellectual disability-progressive spastic diplegia syndrome: genes and variants
Explore variant evidence for Severe intellectual disability-progressive spastic diplegia syndrome across 1 analyzed protein (CTNNB1). Linked ClinVar records include 5 pathogenic or likely pathogenic variants, 13 variants of uncertain significance and 0 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Severe intellectual disability-progressive spastic diplegia syndrome
CTNNB1: Catenin beta-1
It links cadherins to the cytoskeleton at adherens junctions and, when stabilized by Wnt signaling, enters the nucleus to regulate transcription. Activating somatic variants drive many cancers, while germline loss-of-function variants cause CTNNB1 neurodevelopmental disorder.
5 ClinVar pathogenic / likely pathogenic and 13 uncertain variants in CTNNB1 have source records linked to Severe intellectual disability-progressive spastic diplegia syndrome. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Severe intellectual disability-progressive spastic diplegia syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| CTNNB1 S348F | 348 | ARM 5 | Pathogenic / likely pathogenic (★) |
| CTNNB1 L424R | 424 | ARM 7 | Pathogenic / likely pathogenic (★) |
| CTNNB1 G575R | 575 | Pathogenic / likely pathogenic (★) | |
| CTNNB1 E692D | 692 | Pathogenic / likely pathogenic (★) | |
| CTNNB1 G216R | 216 | ARM 2 | Pathogenic / likely pathogenic |
Same protein, different disease
- Pilomatrixoma also has ClinVar records linked to CTNNB1 variants; they fall mostly in different places as the Severe intellectual disability-progressive spastic diplegia syndrome variants (8 pathogenic / likely pathogenic).
- Medulloblastoma also has ClinVar records linked to CTNNB1 variants; they fall mostly in different places as the Severe intellectual disability-progressive spastic diplegia syndrome variants (4 pathogenic / likely pathogenic).
Diseases related to Severe intellectual disability-progressive spastic diplegia syndrome
- Ovarian cancer, also linked to CTNNB1
- Colorectal cancer, also linked to CTNNB1
- Urinary bladder cancer, also linked to CTNNB1
- Colon carcinoma, also linked to CTNNB1
- Ovarian neoplasm, also linked to CTNNB1
- Pilomatrixoma, also linked to CTNNB1
- Hepatocellular carcinoma, also linked to CTNNB1
- Medulloblastoma, also linked to CTNNB1
- Autosomal dominant polycystic liver disease, also linked to CTNNB1
- Desmoid disease, hereditary, also linked to CTNNB1
- Familial exudative vitreoretinopathy, also linked to CTNNB1
Frequently asked questions
Which genes have records linked to Severe intellectual disability-progressive spastic diplegia syndrome?
This view contains 1 analyzed proteins: CTNNB1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 5 pathogenic or likely pathogenic variants, 13 variants of uncertain significance and 0 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 44 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center